Flexibility in the Modelling of Comparative Effectiveness in the Absence of Head-to-Head Comparisons in the NICE Single Technology Appraisal of Fenfluramine for Treating Seizures Associated with Lennox-Gastaut Syndrome: An External Assessment Group Perspective. [PDF]
Fernández Coves A +8 more
europepmc +1 more source
The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression. [PDF]
Le GH +8 more
europepmc +1 more source
From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders. [PDF]
Dinoi G +8 more
europepmc +1 more source
Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study. [PDF]
Cortesi PA +15 more
europepmc +1 more source
Enantioselective comparative analysis of the anticonvulsant potency of fenfluramine and norfenfluramine in mice. [PDF]
Sheeni Y +5 more
europepmc +1 more source
Fenfluramine and Comparative Antiseizure Therapies in Drug-Resistant Epilepsy: A Systematic Review of Efficacy, Cardiometabolic Safety, and Clinical Outcomes. [PDF]
Pal A +7 more
europepmc +1 more source
Genetic Diagnosis in Epilepsy: Implications for Clinical Management. [PDF]
Schatz KS, Lammert DB, Habela CW.
europepmc +1 more source
Fenfluramine for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome. [PDF]
europepmc +1 more source
Breaking the resistance: a narrative review of the evolution from traditional drugs to precision therapies in epilepsy. [PDF]
Patel T +13 more
europepmc +1 more source
Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program. [PDF]
Yang KH +6 more
europepmc +1 more source

